PharmAware Blog

The January 2010 issue of Drug and Therapeutics Bulletin (DTB) [volume 48,
number 1] contains an editorial and three articles. In an editorial and an
accompanying podcast in March 2009, we highlighted issues about ‘high
street mole clinics’. These included concerns that new imaging technologies
might be used in such clinics by clinicians lacking appropriate training.
Our editorial this month discusses some developments in this area.  The
issue also includes a review of the management of medication overuse
headache, a review of the role of cognitive behavioural therapy for
schizophrenia, and a review of tocilizumab for rheumatoid arthritis. A
podcast outlining what is in the January issue is also available via our
website www.dtb.bmj.com.

Confidential documents related to the World Health Organization Expert Working Group on innovative financing for research and development surfaced today, revealing the group’s thinking as well as pharmaceutical industry thinking about the WHO process. The documents immediately raised concern about possible undue access to the process by industry, but the WHO told Intellectual Property Watch the industry group was not supposed to have them.

For full article go to http://www.ip-watch.org/weblog/2009/12/09/confidential-documents-released-fr%0Aom-who-rd-finance-group-pharmaceutical-industry/